Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |